XML 36 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Supplemental Disclosure of Cash Flow Information
 6 Months Ended
Jun. 30, 2020
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information  Supplemental Disclosure of Cash Flow Information
 
Six Months Ended
June 30,
(in thousands)
2020
 
2019
Supplemental Disclosure of Cash Flow Information:
 
 
 
Interest paid
$
107,854

 
$
124,647

Income taxes paid, net of refunds
1,388

 
1,916

 
 
 
 
Capital expenditures, net of related payables:
 
 
 
Capital expenditures - non-development, net
$
82,077

 
$
121,066

Capital expenditures - development, net
6,823

 
10,623

Capital expenditures - non-development - reimbursable
13,923

 
1,000

Trade accounts payable
10,040

 
(10,392
)
Net cash paid
$
112,863

 
$
122,297

Acquisition of communities from Healthpeak:
 
 
 
Property, plant and equipment and leasehold intangibles, net
$
286,734

 
$
—

Operating lease right-of-use assets
(63,285
)
 
—

Financing lease obligations
129,196

 
—

Operating lease obligations
74,335

 
—

Loss (gain) on debt modification and extinguishment, net
(19,731
)
 
—

Net cash paid
$
407,249

 
$
—

Acquisition of other assets, net of related payables and cash received:
 
 
 
Property, plant and equipment and leasehold intangibles, net
$
179

 
$
—

Financing lease obligations
39,260

 
—

Net cash paid
$
39,439

 
$
—

Proceeds from sale of CCRC Venture, net:
 
 
 
Investments in unconsolidated ventures
$
(14,848
)
 
$
—

Current portion of long-term debt
34,706

 
—

Other liabilities
60,748

 
—

Loss (gain) on sale of assets, net
(369,831
)
 
—

Net cash received
$
(289,225
)
 
$
—

Proceeds from sale of other assets, net:
 
 
 
Prepaid expenses and other assets, net
$
(1,261
)
 
$
(5,798
)
Assets held for sale
(5,274
)
 
(41,882
)
Property, plant and equipment and leasehold intangibles, net
(938
)
 
(688
)
Investments in unconsolidated ventures
—

 
(156
)
Other liabilities
(1,862
)
 
(1,762
)
Loss (gain) on sale of assets, net
(1,979
)
 
(2,144
)
Net cash received
$
(11,314
)
 
$
(52,430
)
 
 
 
 
Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities:
 
 
 
Assets designated as held for sale:
 
 
 
Prepaid expenses and other assets, net
$
—

 
$
(5
)
Assets held for sale
—

 
(4,928
)
Property, plant and equipment and leasehold intangibles, net
—

 
4,933

Net
$
—

 
$
—

 
 
 
 

Healthpeak master lease modification:
 
 
 
Property, plant and equipment and leasehold intangibles, net
$
(57,462
)
 
$
—

Operating lease right-of-use assets
88,044

 
—

Financing lease obligations
70,874

 
—

Operating lease obligations
(101,456
)
 
—

Net
$
—

 
$
—

Other lease termination and modification, net:
 
 
 
Prepaid expenses and other assets, net
$
—

 
$
(648
)
Property, plant and equipment and leasehold intangibles, net
13,548

 
(1,666
)
Operating lease right-of-use assets
1,350

 
(5,009
)
Financing lease obligations
(15,483
)
 
—

Operating lease obligations
606

 
5,654

Other liabilities
(21
)
 
(337
)
Loss (gain) on facility lease termination and modification, net
—

 
2,006

Net
$
—

 
$
—



During the three months ended June 30, 2019, the Company and its joint venture partner contributed cash in an aggregate amount of $13.3 million to a consolidated joint venture which owned three senior housing communities. The Company obtained a $6.6 million promissory note receivable from its joint venture partner secured by a 50% equity interest in the joint venture in a non-cash exchange for the Company funding the $13.3 million aggregate contribution in cash.

Restricted cash consists principally of escrow deposits for real estate taxes, property insurance, and capital expenditures required by certain lenders under mortgage debt agreements and deposits as security for self-insured retention risk under workers' compensation programs and property insurance programs. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.
(in thousands)
June 30, 2020
 
December 31, 2019
Reconciliation of cash, cash equivalents, and restricted cash:
 
 
 
Cash and cash equivalents
$
452,441

 
$
240,227

Restricted cash
28,397

 
26,856

Long-term restricted cash
41,292

 
34,614

Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows
$
522,130

 
$
301,697